RxDoctor Payments Data

Krista Molina, MD

Family Medicine · Chesterton, INNPI 1861697781

Payments from drug & device makers

$2,284in general payments, 2019–2025

Across 164 payments — averaging $13.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$321
  • Lilly USA, LLC$226
  • AstraZeneca$207
  • Novo Nordisk$193
  • Boehringer Ingelheim$182
  • Astellas Pharma US Inc$111
  • plus $1K from 24 others

What the payments were for

  • Food & beverage$2,27399%
  • Education$121%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,284 in reported general payments places this provider in the 75th percentile of 2,709 family medicine providers in Indiana.

See all family medicine providers in Indiana

Medicare billing

Part B allowed, 2024
$83,386
Medicare patients
278
Services billed
1,096

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide60$74,029
JardianceEmpagliflozin21$32,250
EliquisApixaban19$20,730
Trelegy ElliptaFluticasone/Umeclidin/Vilanter24$18,002
Spiriva RespimatTiotropium Bromide29$17,259
MounjaroTirzepatide14$17,013
XareltoRivaroxaban11$12,121
LinzessLinaclotide12$11,353
Lantus SolostarInsulin Glargine,hum.Rec.Anlog39$6,390
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr12$5,828
SynthroidLevothyroxine Sodium68$4,671
Valsartan175$3,338
Levothyroxine Sodium336$2,972
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine16$2,698
Atorvastatin Calcium448$2,569

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$193$74,02960 claims
Boehringer IngelheimJardiance, Spiriva Respimat$182$49,50950 claims
GSKTrelegy Ellipta, Anoro Ellipta$54$23,83036 claims
PfizerEliquis$68$20,73019 claims
Lilly USA, LLCMounjaro$226$17,01314 claims
AbbVieLinzess, Synthroid$321$16,02480 claims
Johnson & JohnsonXarelto$109$12,12111 claims
Almatica Pharma LLCSertraline Hcl$42$947206 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,709 family medicine providers in Indiana.

Other family medicine in Chesterton

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →